Amyloid binding agents

US8940918B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8940918-B2
Application numberUS-201013515239-A
CountryUS
Kind codeB2
Filing dateDec 10, 2010
Priority dateDec 10, 2009
Publication dateJan 27, 2015
Grant dateJan 27, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

There are provided compounds and methods for the detection of amyloids and treatment of diseases related to amyloids including Alzheimer's disease and other related amyloid-based neurodegenerative diseases.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound having the structure of Formula (I), wherein EDG is an electron donor group; πCE is a pi-conjugation element; and WSG is a water soluble group; wherein said electron donor group is R 1 -substituted or unsubstituted alkyl, R 1 -substituted or unsubstituted cycloalkyl, R 1 -substituted or unsubstituted heterocycloalkyl, R 1 -sub…

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8940918B2 cover?
There are provided compounds and methods for the detection of amyloids and treatment of diseases related to amyloids including Alzheimer's disease and other related amyloid-based neurodegenerative diseases.
Who is the assignee on this patent?
Yang Jerry, Theodorakis Emmanuel A, Univ California
What technology area does this patent fall under?
Primary CPC classification C07D295/155. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).